Treatment of femoral head osteonecrosis in the United States: 16-year analysis of the Nationwide Inpatient Sample
- PMID: 23943529
- PMCID: PMC3890194
- DOI: 10.1007/s11999-013-3220-3
Treatment of femoral head osteonecrosis in the United States: 16-year analysis of the Nationwide Inpatient Sample
Abstract
Background: Many surgical interventions are used to treat osteonecrosis of the femoral head. The instance and distribution of these various procedures may give some insight into the practicing community's understanding of the efficacy of these treatments. We therefore sought to determine trends in the types and numbers of procedures performed for atraumatic osteonecrosis from 1992 through 2008 in the United States.
Questions/purposes: (1) How has the overall incidence of surgical treatment for atraumatic osteonecrosis changed over this time period; and (2) how has the percentage of THA performed for osteonecrosis (compared with joint-preserving procedures) changed over this time period?
Methods: The Nationwide Inpatient Sample database was used to collect information for all patients who had an International Classification of Diseases, 9(th) Revision diagnosis of hip osteonecrosis between 1992 and 2008. Procedures were collated according to frequency, and trends were analyzed for joint-preserving and joint-replacing procedures.
Results: The total number of procedures performed over this time period for osteonecrosis of the hip increased from 3570 procedures to 6400 procedures per year. In 1992, 75% (n = 2678) of the procedures performed to treat osteonecrosis of the hip were THA, which increased to 88% (n = 5632) in 2008. The percentage of joint-preserving procedures consequently decreased from 25% to 12% over this period.
Conclusions: Previously, THA was believed to have poor survivorship and clinical results for the treatment of osteonecrosis of the hip, but reports since 1993 have suggested improved survivorship of these reconstructions. Our study suggests that surgeons have incorporated this into their practice patterns, in that an increasing percentage of patients with this diagnosis are treated with THA. Additionally, the total number of procedures performed for osteonecrosis has increased, which may reflect an improved awareness of this disease and more aggressive approaches to diagnosis and treatment.
Figures
Similar articles
-
Management of osteonecrosis of the femoral head.Bone Joint J. 2020 Jul;102-B(7_Supple_B):122-128. doi: 10.1302/0301-620X.102B7.BJJ-2019-1611.R1. Bone Joint J. 2020. PMID: 32600203
-
Trends in Surgical Management of Osteonecrosis of the Femoral Head: A 2010 to 2020 Nationwide Study.J Arthroplasty. 2023 Jul;38(7S):S51-S57. doi: 10.1016/j.arth.2023.03.071. Epub 2023 Mar 29. J Arthroplasty. 2023. PMID: 37001624
-
[Surgical treatment concepts for femoral head necrosis].Orthopade. 2007 May;36(5):451-7. doi: 10.1007/s00132-007-1085-4. Orthopade. 2007. PMID: 17479248 Review. German.
-
Difference in Therapeutic Strategies for Joint-Preserving Surgery for Non-Traumatic Osteonecrosis of the Femoral Head between the United States and Japan: A Review of the Literature.Orthop Surg. 2021 May;13(3):742-748. doi: 10.1111/os.12979. Epub 2021 Apr 5. Orthop Surg. 2021. PMID: 33821555 Free PMC article. Review.
-
Trends in Surgical Treatment of Femoral Head Osteonecrosis in South Korea: An Analysis Using Nationwide Claims Database.Clin Orthop Surg. 2022 Dec;14(4):500-506. doi: 10.4055/cios22027. Epub 2022 Sep 28. Clin Orthop Surg. 2022. PMID: 36518932 Free PMC article.
Cited by
-
Time elapsed from definitive diagnosis to surgery for osteonecrosis of the femoral head: a nationwide observational study in Japan.BMJ Open. 2024 Mar 29;14(3):e082342. doi: 10.1136/bmjopen-2023-082342. BMJ Open. 2024. PMID: 38553078 Free PMC article.
-
Unraveling the Role of Endothelial Dysfunction in Osteonecrosis of the Femoral Head: A Pathway to New Therapies.Biomedicines. 2024 Mar 15;12(3):664. doi: 10.3390/biomedicines12030664. Biomedicines. 2024. PMID: 38540277 Free PMC article. Review.
-
Evaluation of the long-term patient-reported outcomes after hip arthroplasty or joint preserving with Sugioka femoral osteotomy in patients with femoral head osteonecrosis.Int Orthop. 2024 May;48(5):1201-1208. doi: 10.1007/s00264-024-06118-3. Epub 2024 Feb 20. Int Orthop. 2024. PMID: 38376531 Free PMC article.
-
The protective role of vitamins C and E in steroid-induced femoral head osteonecrosis: An experimental study in rats.Jt Dis Relat Surg. 2024 Jan 1;35(1):72-84. doi: 10.52312/jdrs.2023.1405. Epub 2023 Nov 2. Jt Dis Relat Surg. 2024. PMID: 38108168 Free PMC article.
-
Identification of key genes and pathways associated with gender difference in osteonecrosis of the femoral head based on bioinformatics analysis.J Musculoskelet Neuronal Interact. 2023 Mar 1;23(1):122-130. J Musculoskelet Neuronal Interact. 2023. PMID: 36856107 Free PMC article.
References
-
- Acurio MT, Friedman RJ. Hip arthroplasty in patients with sickle-cell haemoglobinopathy. J Bone Joint Surg Br. 1992;74:367–371. - PubMed
-
- Adili A, Trousdale RT. Femoral head resurfacing for the treatment of osteonecrosis in the young patient. Clin Orthop Relat Res. 2003;417:93–101. - PubMed
-
- Agency for Healthcare Research and Quality. Introduction to the HCUP Nationwide Inpatient Sample (NIS) 2010. Available at: http://www.hcup-us.ahrq.gov/db/nation/nis/NISIntroduction2010.pdf. Accessed January 1, 2013.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
